Platinum-Based Anticancer Chemotherapy Tissue Toxicity: The Use of Carrot and Tomato Supplements as a Dietary Intervention in Rattus norvegicus doi.org/10.26538/tjnpr/v4i10.18
Main Article Content
Abstract
High-dose of cisplatin therapy is limited due to its cumulative toxicity. Recently, diverse natural product and dietary compounds have been exploited as potential protective agents against cisplatin-induced tissue toxicity. This paper aims to examine the effect of a supplementary diet of carrot and tomato against cisplatin-induced dyslipidemia and hepatic transaminase changes and the risk of cardiovascular diseases in male Wistar rats. Male albino rats weighing (98.4+2.4g) were randomly assigned into five groups (n=6). Group one served as control and was maintained on a control diet for 7days. Rats of groups 2, 3, 4, and 5 were injected a single dose of cisplatin (7.5mg/kg/body weight) and thereafter fed with a control diet, 5% carrot, 5% tomato, and 5% tomato + 5%carrot supplemented diet respectively. The result revealed that cisplatin caused bodyweight loss, increases the plasma total cholesterol,
triglyceride, LDL, AST, ALP, and ALT level significantly. Conversely, it causes a decrease in the plasma HDL cholesterol level. However, supplementation with tomato and carrot causes a decrease in the plasma level of total cholesterol, triglyceride, LDL AST, ALP, and ALT level towards normal (control). Additionally, the atherogenic parameters were observed to be slightly high upon cisplatin injection whereas treatment with tomato and carrot significantly reduced the atherogenic parameters towards normal (control). These findings suggest the positive effects of tomato and carrot supplementation against cisplatin-induced dyslipidemia, hepatotoxicity, and risk of cardiovascular diseases. Accordingly, carrot and tomato supplementation might serve as unique supplements that can be used in
conjunction with cisplatin chemotherapy.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Wang G, Reed E, Li QQ. Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). Oncol Rep. 2004; 12:955-965.
Fruscio R, Garbi A, Parma G, Lissoni AA, Garavaglia D,Bonazzi CM, Dell’anna T, Mangioni C, Milani R, Colombo N. Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer. J Natl Cancer Inst. 2011; 103:347–351.
Byrski T, Dent R, Blecharz P, Foszczynska-Kloda M, Gronwald J, Huzarski T, Cybulski C, Marczyk E, Chrzan R, Eisen A, Lubinski J, Narod SA. Results of a phase II openlabel, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer.
Breast Cancer Res 2012; 20(4):14.
Zustovich F, Lombardi G, Della Puppa A, Rotilio A, Scienza R, Pastorelli D. A phase II study of cisplatin and temozolomidein heavily pre-treated patients with temozolomide-refractory high-grade malignant glioma. Anticancer Res. 2009; 29:4275–4279.
Kentepozidis N, Kotsakis A, Soultati A, Agelaki S, ChristophylakisCh, Agelidou M, Chelis L, Papakotoulas P, Vamvakas L, Zafiriou Z, Samonis G, Georgoulias V. Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/Metastatic non-squamous nonsmall-cell lung cancer: a multicenterphase II study of the Hellenic Oncology Research Group. Cancer Chemother Pharmacol. 2013; 71:605–612.
Seiter K, Katragadda S, Ponce D, Rasul M, Ahmed N. Temozolomide and cisplatin in relapsed/refractory acute leukemia. J Hematol Oncol. 2009; 2:21.
Fukasawa H, Furuya R, Yasuda H, Yamamoto T, Hishida A, Kitagawa M. Anti-cancer agent-induced nephrotoxicity. Anti-Cancer Agent Met. 2014; 14(7):921– 927.
Aly MS, Ashour MB, El-Nahas SM, Abo-Zeid MAF. Genotoxicity and cytotoxicity of the anticancer drugs gemcitabine and cisplatin, separately and in combination: In vivo studies. J Biol Sci. 2003; 3:961-972.
Ajani JA. Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: Evolution of the docetaxel, cisplatin and 5-fluorouracil regimen. Cancer 2008; 113:945-955.
Dank M, Zaluski J, Barone C, Valvere V, Yalcin S, Peschel C, Wenczl M, Goker E, Cisar L, Wang K, Bugat R.Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction. Ann Oncol. 2008; 19:1450-1457.
Lubinski J and Narod SA. Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer. Breast Cancer Res. 2012; 14 (4):R110.
Waseem M, Bhardwaj M, Tabassum H, Raisuddin S, Parvez S. Drug Chem Toxicol. 2015; 38:452–459.
Ezz-Din D, Gabry MS, Farrag AR, Abdel-Moneim AE. Physiological and histological impact of Azadirachtaindica (neem) leaves extract in a rat model of cisplatin-induced hepato and nephrotoxicity. J Med Plants Res. 2011; 5:5499-5506.
Attyah AM and Ismail SH. Protective effect of ginger extract against cisplatin-induced hepatotoxicity and cardiotoxicity in rats. Iraqi J Pharm Sci. 2012; 21(1):27 -33.
Kim SH, Hong KO, Chung WY, Hwang JK, Park KK, 2004. Abrogation of cisplatin-induced hepatotoxicity in mice by xanthorrhizol is related to its effect on the regulation of gene transcription. Toxicol Appl Pharmacol. 2004; 196:346-355.
Pal S, Sadhu AS, Patra S, Mukherjea KK. Histological vs. biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt-ATP on experimental animal models. J Exp Clin Cancer Res. 2008; 27:68-68.
Kim KS, Joseph B, Inada M, Gupta S. Regulation of hepatocyte engraftment and proliferation after cytotoxic drug-induced perturbation of the rat liver. Transplantation 2005; 80:653-659.
Venkatesan PN, Rajendran P, Ekambaram G, Sakthisekaran D. Combination therapeutic effect of cisplatin along with Solanumtrilobatum on benzo(a)pyrene induced experimental lung carcinogenesis. Nat Prod Res. 2008; 22:1094-1106.
Kopin L and Lowenstein CJ. Dyslipidemia. Ann Intern Med. 2017; 167:ITC81–ITC96.
Wang G, Su C, Yin T. Paclitaxel and platinum-based chemotherapy results in transient dyslipidemia in cancer patients. Mol Clin Oncol. 2017; 6(2):261-265.
Jacob K, Periago MJ, Bohm V, Berruezo GR. Influence of Lycopene and Vitamin C From Tomato Juice on Biomarkers of Oxidative Stress and Inflammation. Brit J Nutr. 2008; 99:137–146.
Li H, Deng Z, Liu R, Loewen S, Tsao R. Carotenoid Compositions of Coloured Tomato Cultivars and Contribution to Antioxidant Activities and Protection Against H O-Induced Cell Death in H9c2. Food Chem. 2013; 136:878–888.
Shahidi F and Ambigaipalan P. Phenolics and Polyphenolics in Foods, Beverages and Spices: Antioxidant Activity and Health Effects—A Review. J Funct. 2015; 18:820–897.
Helyes L and Lugasi A. Formation of Certain Compounds Having Technological and Nutritional Importance in Tomato Fruits During Maturation. Acta Alimentaria 2006; 35:183–193.
Toor RK and Savage GP. Antioxidant Activity in Different Fractions of Tomatoes. Food Res Int. 2005; 38:487–494.
ElAiraj H, Gest N, Truffault V, Garchery C, Riqueau G, Gouble B, Page D, Stevens R. Decreased Monodehydroascorbate Reductase Activity Reduces Tolerance to Cold Storage in Tomato and Affects Fruit Antioxidant Levels. Postharvest Biol Technol. 2013; 86:502–510.
Hashimoto T and Nagayama T. Chemical composition of ready to eat fresh carrot. J Food Hyg Soc Japan 2004; 39: 324-328.
Beom J, Yong S, Myung H. Antioxidant activity of vegetables and blends in iron catalyzed model system. J Food Sci Nutr. 1998; 3:309-314.
Sun MS, Mihyang K, Song JB. Cytotoxicity and quinine reductase induced effects of Daucas carrot leaf extracts on human cancer cells. Kor J Food Sci. 2001; 30:86-91.
Seo A and Yu M. Toxigenic fungi and mycotoxins, in: handbook of industrial mycology (Andrea, Z ed.). Academic Press London 2003. 233-246 p.
Reitman S and Frankel S. A colorimetric method for determination of serum glutamate oxaloacetate and glutamic pyruvate transaminase. Am J Clin Pathol. 1957; 28:56-58.
Kind PR and King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol. 1954; 7(4):322-326.
Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952; 195:357–366.
Tietz NW. Serum triglyceride determination. In: clinical guide to laboratory tests, second edition, W.B. Saunders CO, Philadelphia, USA 1990. 554-556 p.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499–502.
Cabezos PA, Vera G, Castillo M, Fernandez-Pujol R, Martin MI, Abalo R. Radiological study of gastrointestinal motor activity after acute cisplatin in the rat. Temporal relationship with pica. Auton Neurosci. 2008; 141:54-65.
Lee CK, Park KK, Lim SS, Park JH, Chung WY. Effects of the licorice extract against tumor growth and cisplatininduced toxicity in a mouse xenograft model of colon cancer. Bio Pharm Bull. 2007; 30:2191-2195.
Green R and Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterol. 2002; 124(4):1367-1384.
Shahjahan M, Malika K, Sabitha M, Maladevi C. Effect of Solanum Trilobatum against carbon tetrachloride induced hepatic damage in albino rats. Indian J Med Res. 2004; 120:194 – 198.
Hill JM, Loeb E, MacLellan, Hill NO, Khan A, King JJ. Clinical studies of platinum coordination compounds in the treatment of various malignant diseases. Cancer Chemother Rep. 1975; 59:647-659.
King PD and Perry MC. Hepatotoxicity of chemotherapy. Oncologist 2001; 6(2):162-176.
Karadeniz A, Simsek N, Karakus E, Yildirim S, Kara A. Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin. Oxid Med Cell Longev 2011; 981793.
Alibakhshi T, Khodayar MJ, Khorsandi L, Rashno M, Zeidooni L. Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity. Biomed Pharmacother. 2018; 105:225–232.
Zheng XN, Wang XW, Li LY, Xu ZW, Huang HY, Zhao JS, (2013). Pu-erh tea powder preventive effects on cisplatin-induced liver oxidative damage in Wistar rats. Asian Pac J Cancer Prev. 2013; 15(17):7389-7394.
Saleh RM, Awadin WF, Elseady YY, Waheish FE. Renal and Cardiovascular Damage Induced by Cisplatin in Rats. Life Sci. 2014; 11(2):191-203.
Reddy JK and Rao MS. Lipid metabolism and liver inflammation. II fatty liver disease and fatty acidoxidation. Am J Physiol Gastrointest Liver Physiol 2006; 290:852- 888.
Chan L. Apolipoprotein B, the major protein component of triglyceride-rich and low-density lipoproteins. J Biol Chem. 1992; 267:25621-25624.
Mohammadi A, Macri J, Newton R, Romain T, Dulay D, Adeli K. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells. Arterioscl Thromb Vasc Biol.1998; 18:783-793.
Karakus E, Karadeniz A, Simsek N, Can I, Kara A, Yildirim S, Kalkan Y, Kisa F. Protective effect of Panax ginseng against serum biochemical changes and apoptosis in liver of rats treated with carbon tetrachloride (CCl4). J Hazard Mater. 2011; 195:208-213.
Leeja L and Thoppil JE. Antimicrobial activity of methanol extract of Origanummajorana L. (Sweet marjoram). J Environ Biol. 2007; 28:145-146.
Bushuty DH and Shanshan NM. Effect of natural herbs of marjoram and ginger on hypercholestrolemic rats. Annual Conference 2012; (7th Arabian-4th International), 1755- 1766 p.
Brown MS and Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Sci. 1986; 232:34-47.
Gould K, Davies KM, Winefield C. Anthocyanins: biosynthesis, functions, and applications. New York, NY: Springer; 2009. 86-105 p